CID 16131646

Isis 9035

Structural Information

Molecular Formula
C98H124N37O51P9S9
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3CO)N4C=NC5=C4N=C(NC5=O)N)OP(=S)(O)OCC6C(CC(O6)N7C=NC8=C7N=C(NC8=O)N)OP(=O)(OCC9C(CC(O9)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)O)S
InChI
InChI=1S/C98H124N37O51P9S9/c1-37-18-128(96(147)123-83(37)138)65-12-44(54(172-65)25-160-188(151,197)178-41-9-69(168-50(41)21-136)133-34-110-74-80(133)116-91(103)120-87(74)142)182-193(156,202)167-30-59-49(17-71(177-59)135-36-112-76-82(135)118-93(105)122-89(76)144)186-194(157,203)162-24-53-42(10-63(171-53)126-6-4-60(99)113-94(126)145)179-189(152,198)163-26-55-45(13-66(173-55)129-19-38(2)84(139)124-97(129)148)181-191(154,200)161-23-52-43(11-64(170-52)127-7-5-61(100)114-95(127)146)180-190(153,199)165-28-57-47(15-68(175-57)131-32-108-72-77(101)106-31-107-78(72)131)185-195(158,204)164-27-56-46(14-67(174-56)130-20-39(3)85(140)125-98(130)149)183-192(155,201)166-29-58-48(16-70(176-58)134-35-111-75-81(134)117-92(104)121-88(75)143)184-187(150,196)159-22-51-40(137)8-62(169-51)132-33-109-73-79(132)115-90(102)119-86(73)141/h4-7,18-20,31-36,40-59,62-71,136-137H,8-17,21-30H2,1-3H3,(H,150,196)(H,151,197)(H,152,198)(H,153,199)(H,154,200)(H,155,201)(H,156,202)(H,157,203)(H,158,204)(H2,99,113,145)(H2,100,114,146)(H2,101,106,107)(H,123,138,147)(H,124,139,148)(H,125,140,149)(H3,102,115,119,141)(H3,103,116,120,142)(H3,104,117,121,143)(H3,105,118,122,144)
InChIKey
UEKUDJMOBKLYLD-UHFFFAOYSA-N
Compound name
1-[4-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-sulfanylphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-2-yl]-5-methylpyrimidine-2,4-dione
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

3201.3372 Da
Monoisotopic Mass

-5.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3202.3445 295.5
[M+Na]+ 3224.3264 299.1
[M-H]- 3200.3299 296.2
[M+NH4]+ 3219.3710 296.9
[M+K]+ 3240.3004 297.3
[M+H-H2O]+ 3184.3345 295.9
[M+HCOO]- 3246.3354 297.1
[M+CH3COO]- 3260.3511 297.5
[M+Na-2H]- 3222.3119 300.2
[M]+ 3201.3367 299.1
[M]- 3201.3377 299.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.